Clofibrate for prevention of myocardial infarction.
出版信息
Med Lett Drugs Ther. 1973 Apr 27;15(9):37-8.
PMID:4704699
Abstract
摘要
相似文献
1
Clofibrate for prevention of myocardial infarction.
Med Lett Drugs Ther. 1973 Apr 27;15(9):37-8.
2
Clofibrate in the treatment and prevention of ischaemic heart disease: recent trials.
Drug Ther Bull. 1972 Aug 18;10(17):65-6.
3
Long-term therapy of ischaemic heart disease.缺血性心脏病的长期治疗。
Arzneimittelforschung. 1972 Oct;22(10):1835-40.
4
Cholesterol, coronaries, clofibrate and death.胆固醇、冠状动脉、氯贝丁酯与死亡
N Engl J Med. 1978 Dec 14;299(24):1360-2. doi: 10.1056/NEJM197812142992409.
5
6
7
Editorial: The value of clofibrate in coronary heart disease.
Am Heart J. 1974 Jan;87(1):1-4. doi: 10.1016/0002-8703(74)90382-2.
8
Secondary prevention trials using clofibrate: a joint commentary on the Newcastle and Scottish trials.使用氯贝丁酯的二级预防试验：关于纽卡斯尔和苏格兰试验的联合评论
Br Med J. 1971 Dec 25;4(5790):784-6. doi: 10.1136/bmj.4.5790.784.
9
Ischemic heart disease: a secondary prevention trial using clofibrate (Atromid-S).缺血性心脏病：一项使用氯贝丁酯（安妥明）的二级预防试验。
Adv Exp Med Biol. 1972;26(0):255-9. doi: 10.1007/978-1-4684-7547-0_21.
10
Editorial: After a coronary.社论：冠心病之后
Br Med J. 1975 Apr 19;2(5963):103-5.
引用本文的文献
1
Clofibrate disposition in renal failure and acute and chronic liver disease.氯贝丁酯在肾衰竭以及急慢性肝病中的处置情况。
Eur J Clin Pharmacol. 1979 Jun 12;15(5):341-7. doi: 10.1007/BF00558438.
Zotero 插件